Impact of Rituximab on COVID-19 in Immunocompromised Patients: A Nationwide Cohort Study in Korea - Quiz - MDSpire

Impact of Rituximab on COVID-19 in Immunocompromised Patients: A Nationwide Cohort Study in Korea

  • By

  • Chan Mi Lee

  • Suhyun Kim

  • Hyeon Jae Jo

  • Chang Kyung Kang

  • Wan Beom Park

  • Nam Joong Kim

  • Seungyeon Kim

  • Pyoeng Gyun Choe

  • April 29, 2025

  • 0 min

Share

Original Source(s)

Impact of Rituximab on COVID-19 in Immunocompromised Patients: A Nationwide Cohort Study in Korea

  • by Chan Mi Lee, Suhyun Kim, Hyeon Jae Jo, Chang Kyung Kang, Wan Beom Park, Nam Joong Kim, Seungyeon Kim, Pyoeng Gyun Choe

  • April 29, 2025

Related Content

Age and hypoalbuminemia independently predict pulmonary consolidation in children with 23S rRNA A2063G-mutant Mycoplasma pneumoniae pneumonia: a retrospective single-center study

Ebola at the World Cup? Here’s what we should actually worry about

A CDC page on mpox caught in political crosshairs